<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Novartis Ag</title><link href="http://guidetoinsomnia.com/topic/novartis-ag" rel="alternate"></link><id>http://guidetoinsomnia.com/topic/novartis-ag</id><updated>2010-09-30T12:45:39Z</updated><entry><title>Novartis Settlement</title><link href="http://guidetoinsomnia.com/photo/novartis-settlement-2354774p" rel="alternate"></link><updated>2010-09-30T12:45:39Z</updated><author><name>AP News</name></author><id>tag:guidetoinsomnia.com,2010-09-30:/photo/novartis-settlement-2354774p/</id><summary type="html">&lt;a title="Zane David Memeger" href="/topic/Zane+David+Memeger" &gt;U.S. Attorney Zane David Memeger&lt;/a&gt; smiles after speaking during a news conference about &lt;a title="Novartis AG" href="/topic/Novartis+AG" &gt;Novartis Pharmaceuticals Corp.&lt;/a&gt;, Thursday, Sept. 30, 2010, in &lt;a title="Philadelphia" href="/topic/Philadelphia" &gt;Philadelphia&lt;/a&gt;. The &lt;a title="U.S. Department of Justice" href="/topic/U.S.+Department+of+Justice" &gt;U.S. Justice Department&lt;/a&gt; says the pharmaceutical maker has agreed to pay $...</summary><category term="Epilepsy"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="U.S. Department of Justice"></category><category term="Philadelphia"></category><category term="Novartis AG"></category><category term="Trileptal"></category><category term="Brain and Nerve Health"></category><category term="Zane David Memeger"></category></entry><entry><title>Novartis results</title><link href="http://guidetoinsomnia.com/photo/novartis-results-635968p" rel="alternate"></link><updated>2010-04-13T09:32:41Z</updated><author><name>ZUMA Press Inc</name></author><id>tag:guidetoinsomnia.com,2010-04-13:/photo/novartis-results-635968p/</id><summary type="html">&lt;a title="Daniel Vasella" href="/topic/Daniel+Vasella" &gt;Daniel Vasella, Chief Executive Officer&lt;/a&gt;  of Swiss pharmaceutical group &lt;a title="Novartis AG" href="/topic/Novartis+AG" &gt;Novartis&lt;/a&gt;, is projected on a screen as he speaks during the general assembly of Novartis in &lt;a title="Basel" href="/topic/Basel" &gt;Basel&lt;/a&gt;, &lt;a title="Switzerland" href="/topic/Switzerland" &gt;Switzerland&lt;/a&gt;, Tuesday, February 24, 2009
&lt;div id="copyright"&gt;&lt;div&gt;
        Copyright 2009  &lt;a href="http://www.zumapress.c...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Europe"></category><category term="Switzerland"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Basel"></category><category term="Daniel Vasella"></category></entry><entry><title>Novartis press conference</title><link href="http://guidetoinsomnia.com/photo/novartis-press-conference-145654p" rel="alternate"></link><updated>2010-04-18T10:09:38Z</updated><author><name>ZUMA Press Inc</name></author><id>tag:guidetoinsomnia.com,2010-04-18:/photo/novartis-press-conference-145654p/</id><summary type="html">epa01616452 &lt;a title="Daniel Vasella" href="/topic/Daniel+Vasella" &gt;Daniel Vasella, CEO&lt;/a&gt; Novartis, center, speaks to  the media, while &lt;a title="Joerg Reinhardt" href="/topic/Joerg+Reinhardt" &gt;Joerg Reinhardt&lt;/a&gt;, Chief Operating Officer, left, and &lt;a title="Raymund Breu" href="/topic/Raymund+Breu" &gt;Raymund Breu&lt;/a&gt;, Chief Financial Officer, right, during the full-year results 2008 press conference in &lt;a title="Basel" href="/topic/Basel" &gt;Basel&lt;/a&gt;, &lt;a title="Switzerland" href="/topic/Switzer...</summary><category term="Media"></category><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="Earnings and Losses"></category><category term="Contagious and Infectious Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Vaccines"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Europe"></category><category term="Switzerland"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Basel"></category><category term="Daniel Vasella"></category><category term="Raymund Breu"></category><category term="Joerg Reinhardt"></category></entry><entry><title>Daniel Vasella, CEO Novartis speaks to Joerg Reinhardt, Chief Operating Officer</title><link href="http://guidetoinsomnia.com/photo/daniel-vasella-ceo-novartis-speaks-joerg-reinhardt-chief-operating-officer-145455p" rel="alternate"></link><updated>2010-04-18T10:13:12Z</updated><author><name>ZUMA Press Inc</name></author><id>tag:guidetoinsomnia.com,2010-04-18:/photo/daniel-vasella-ceo-novartis-speaks-joerg-reinhardt-chief-operating-officer-145455p/</id><summary type="html">epa01616429 &lt;a title="Daniel Vasella" href="/topic/Daniel+Vasella" &gt;Daniel Vasella, CEO&lt;/a&gt; Novartis (R), speaks to &lt;a title="Joerg Reinhardt" href="/topic/Joerg+Reinhardt" &gt;Joerg Reinhardt&lt;/a&gt;, Chief Operating Officer (L), during the full-year results 2008 press conference in &lt;a title="Basel" href="/topic/Basel" &gt;Basel&lt;/a&gt;, &lt;a title="Switzerland" href="/topic/Switzerland" &gt;Switzerland&lt;/a&gt;, 28 January  2009. Swiss pharmaceutical giant &lt;a title="Novartis AG" href="/topic/Novartis+AG" &gt;Novartis&lt;/a...</summary><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="Earnings and Losses"></category><category term="Contagious and Infectious Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Vaccines"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Europe"></category><category term="Switzerland"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Basel"></category><category term="Daniel Vasella"></category><category term="Joerg Reinhardt"></category></entry><entry><title>Joerg Reinhardt, Chief Operating Officer of Novartis</title><link href="http://guidetoinsomnia.com/photo/joerg-reinhardt-chief-operating-officer-novartis-145453p" rel="alternate"></link><updated>2010-04-18T10:13:15Z</updated><author><name>ZUMA Press Inc</name></author><id>tag:guidetoinsomnia.com,2010-04-18:/photo/joerg-reinhardt-chief-operating-officer-novartis-145453p/</id><summary type="html">epa01616427 &lt;a title="Joerg Reinhardt" href="/topic/Joerg+Reinhardt" &gt;Joerg Reinhardt&lt;/a&gt;, Chief Operating Officer, speaks to the media during the full-year results 2008 press conference in &lt;a title="Basel" href="/topic/Basel" &gt;Basel&lt;/a&gt;, &lt;a title="Switzerland" href="/topic/Switzerland" &gt;Switzerland&lt;/a&gt;, 28 January  2009. Swiss pharmaceutical giant &lt;a title="Novartis AG" href="/topic/Novartis+AG" &gt;Novartis&lt;/a&gt; reported Wednesday a 25 percent jump in profits in 2008 to 8.16 billion dollars (6.2 b...</summary><category term="Media"></category><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="Earnings and Losses"></category><category term="Contagious and Infectious Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Vaccines"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Europe"></category><category term="Switzerland"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Basel"></category><category term="Joerg Reinhardt"></category></entry></feed>
